Beschreibung:
Introduction CGM use is lowest among minority youth in the US. This QI project aims to increase active CGM use from 39% to 70% and reduce CGM attrition from 74% to 30% among NHB and Latinx youth with T1D. Methods We distributed CGM adhesive kits with overlay patches and adhesive wipes to youth with diabetes, with instructions on use and how to purchase. PDSA cycles were completed in an iterative process. Demographic and CGM use data (“active”, “attrition”, or “never”) were obtained over 9 months. Chi square tests compared data between NHB/Latinx youth who received versus did not receive kits at 3, 6, and 9 months from project initiation. Results 103 kit-receiving youth (Mage 12.8±4.5, Male 51.0%, NHB 71.8%, Latinx 28.2%,T1D 81.6%) were compared with 917 youth seen in clinic over the same period who did not receive kits (Mage 14.4±4.1, Male 47.0%, NHB 70.1%, Latinx 29.9%, T1D 65.1%). CGM use rates are described in Figure 1. From baseline to follow-up, current CGM use increased and never CGM use decreased among those that received kits, while current and never CGM use rates remained relatively unchanged among non-kit receivers. At final visit, 48% of never users and 29.3% with CGM attrition prior to receiving kits became active users. Conclusions There was a greater increase in active CGM use and decrease in never CGM use among NHB and Latinx youth who received CGM adhesive kits. QI projects can help to promote equity in use of diabetes technologies. Disclosure J.Grundman: Research Support; American Diabetes Association, Dexcom, Inc. A.G.Perkins: Research Support; Tandem Diabetes Care, Inc., Dexcom, Inc. J.K.Reilly: None. S.L.Holly: None. S.Bowers: None. L.Clary: None. S.Majidi: None.